|Bid||282.77 x 200|
|Ask||282.89 x 100|
|Day's Range||282.26 - 286.00|
|52 Week Range||244.28 - 329.83|
|PE Ratio (TTM)||17.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Key highlights include regulatory approvals for companies like Alexion (ALXN) and Ironwood while Biogen is one of the companies facing an investigation into the pricing of multiple sclerosis drugs.
Allergan’s (AGN) international business includes total revenues from the sales of branded products as well as aesthetics products outside the US markets.
Technology stocks led the S&P 500 on Tuesday, but in exchange-traded fund land, those tracking biotech stocks were the real winners. The SPDR S&P Biotech ETF (XBI) and First Trust NYSE Arca Biotechnology ...